2010
DOI: 10.1111/j.1537-2995.2010.02634.x
|View full text |Cite
|
Sign up to set email alerts
|

A case‐control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME)

Abstract: Background/aims NAT is performed on blood collected in the United States allowing for the classification of HCV antibody positive donors into resolved and chronic hepatitis C infections. We report a case-control study of factors associated with HCV resolution. Methods Blood donors with resolved (HCV Ab+, RNA- defined as “cases”) or chronic (HCV Ab+, RNA+ defined as “controls”) based on their index donation HCV test results were enrolled. Participants completed a risk factor, symptoms and treatment questionna… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 45 publications
(49 reference statements)
0
15
0
Order By: Relevance
“…While it is possible that body mass index, baseline alcohol use, or baseline HCV RNA may account for differences seen among racial/ethnic groups, studies adjusting for these factors, including our study which accounted for a host of potential confounders, continue to observe marked racial/ethnic differences [18, 19]. Recent data show that immunogenetics explain a large part of spontaneous HCV clearance.…”
Section: Discussionmentioning
confidence: 80%
“…While it is possible that body mass index, baseline alcohol use, or baseline HCV RNA may account for differences seen among racial/ethnic groups, studies adjusting for these factors, including our study which accounted for a host of potential confounders, continue to observe marked racial/ethnic differences [18, 19]. Recent data show that immunogenetics explain a large part of spontaneous HCV clearance.…”
Section: Discussionmentioning
confidence: 80%
“…The study sites include the AIDS Link to the Intravenous Experience (ALIVE)(8), Baltimore Before and After Acute Study of Hepatitis (BBAASH)(9), Boston Area HCV Study Transmission, Immunity, Outcomes Network (BAHSTION)(10), Cramp (11), Hemophilia Growth and Development Cohort (HGDS)(12), Mangia(13), Multicenter Hemophilia Cohort Studies (MHCS I and II)(14), Correlates of Resolved Versus Low-Level Viremic Hepatitis C Infection in Blood Donors (REVELL Study) (15), The Swan Project(16), Toulouse cohort(17), Women’s Interagency HIV Study (WIHS)(18), and United Kingdom Drug Use cohort(19). Study sites were selected because they had well established HCV outcomes, available DNA and permission for genetic testing.…”
Section: Methodsmentioning
confidence: 99%
“…Some factors have been associated with this situation, such as differences in immune response, ethnic background, and parenteral exposure. 2,3 Recently, single nucleotide polymorphisms (SNP) near the gene of interleukin 28B (IL28B), which encodes a type III interferon (IFN-lambda3), were identified as genetic determinants of spontaneous resolution of HCV infection. Specifically, one polymorphism (rs12979860) was associated with the response to standard treatment for HCV (pegylated interferon plus ribavirin) in coinfected HCV/HIV-1 individuals.…”
Section: Introductionmentioning
confidence: 99%